Skip to content

B2 Microglobulin

by Medicon Hellas SA Greece EUDAMED

Ref 1418-0865

EMDN W0102039002

Regulatory status

as of 25 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/IVDD NumberB-05204309057825 Basic UDI-DIDate11 Dec 2023RegisteredStatusActive

Coverage

1 jurisdiction

SwedenFinlandFinlandSwedenFinlandFinlandSwedenSwedenLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyGermanyPolandPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaPolandFranceFranceAustriaHungaryRomaniaFranceFranceSloveniaBulgariaPortugalSpainSpainItalySpainSpainCroatiaGreeceMaltaCyprus
  • Expiring (legacy directive)
  • Not covered

European Union — CE/IVDD Expiring (legacy directive)

Certificates: none listed in EUDAMED

Specification

EUDAMED · synced 24 Oct 2026

Model / Reference
1418-0865
Primary DI / UDI-DI
05204309057825
Basic UDI-DI
B-05204309057825
EMDN Code
W0102039002 Beta2-microglobulin
Device Class
Class IVD General
Market of Registration
Greece

Manufacturer details

EUDAMED SRN
GR-MF-000013625

Other devices from Medicon Hellas SA

See all devices from Medicon Hellas SA →

Properties & raw data

Show properties, registry sources and raw records
  • Animal Tissues
  • Reagent
  • Professional Testing
Other properties (7)
  • Sterile: No
  • Human Tissues: No
  • Microbial Substances: No
  • Self Testing: No
  • Near-Patient Testing: No
  • Companion Diagnostics: No
  • Surgical Instrument: No

Sources (1)

  • EUDAMED 8dd5f904-d1c5-4b0d-adb5-d7965a04aa8c 61 fields · synced 24 Oct 2026